Literature DB >> 16469532

Alteration of serum cytokine balances among different phases of chronic hepatitis B virus infection.

Minoru Ayada1, Tetsuya Ishikawa, Akihiko Okumura, Junichi Tanabe, Hiroyasu Ito, Tomohiko Ohashi, Eiji Matsumoto, Ken Sato, Naoki Hotta, Yoshitaka Fukuzawa, Sinichi Kakumu.   

Abstract

To understand the pathogenesis of chronic hepatitis B virus (HBV) infection, we examined the serum levels of IL-10, TNF-alpha IL-12 p70, and IL-12 p40 in 77 patients chronically infected with HBV and 19 controls. The patients were classified into four groups: asymptomatic carriers (ASC), patients with chronic hepatitis (CH), patients with liver cirrhosis (LC), and patients with hepatocellular carcinomas (HCC). The cytokine values among these groups were compared and their relations to clinical parameters were investigated. All these cytokine values were higher in the patient groups than in controls. IL-10 and TNF-alpha became higher in accordance with the progress of the disease phases, from ASC to LC, and lowest when the patients had HCC. IL-12 p40 was also lowest in HCC, however, the group with highest levels was CH. IL-12 p70 was unchanged among ASC, CH, and LC, but were raised in HCC. Serial analyses for the cytokine values in the same patients showed the similar tendencies. Regression analysis showed the significant correlations between ALT and IL-10. Serum cytokine values well reflected the pathological differences of the individual disease phases, and may become useful indices to understand the pathogenesis of chronic HBV infection.

Entities:  

Year:  2006        PMID: 16469532     DOI: 10.1016/j.hepres.2006.01.001

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  7 in total

1.  Serum cytokine levels in patients with chronic hepatitis B according to lamivudine therapy.

Authors:  Younhee Park; Yongjung Park; Kwang-Hyub Han; Hyon-Suk Kim
Journal:  J Clin Lab Anal       Date:  2011-11       Impact factor: 2.352

2.  Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individuals.

Authors:  Christina M Martin; Jeffrey A Welge; Norah J Shire; Mohamed T Shata; Kenneth E Sherman; Jason T Blackard
Journal:  Cytokine       Date:  2009-07-21       Impact factor: 3.861

3.  IFN-γ (+874) and not TNF-α (-308) is associated with HBV-HCC risk in India.

Authors:  Roli Saxena; Yogesh Kumar Chawla; Indu Verma; Jyotdeep Kaur
Journal:  Mol Cell Biochem       Date:  2013-10-08       Impact factor: 3.396

4.  Association of interleukin-10 with hepatitis B virus (HBV) mediated disease progression in Indian population.

Authors:  Roli Saxena; Yogesh Kumar Chawla; Indu Verma; Jyotdeep Kaur
Journal:  Indian J Med Res       Date:  2014-05       Impact factor: 2.375

5.  Evaluation of serum interleukin-10 levels in hepatocellular carcinoma patients: a systematic review and meta-analysis.

Authors:  Ebrahim Shakiba; Mazaher Ramezani; Masoud Sadeghi
Journal:  Clin Exp Hepatol       Date:  2018-02-09

6.  Immune Checkpoint Molecules Expressed on CD4+ T Cell Subsets in Chronic Asymptomatic Hepatitis B Virus Carriers With Hepatitis B e Antigen-Negative.

Authors:  Dawei Cui; Daixi Jiang; Cuilin Yan; Xia Liu; Yan Lv; Jue Xie; Yu Chen
Journal:  Front Microbiol       Date:  2022-04-27       Impact factor: 5.640

7.  Rather than Rs1800796 polymorphism, expression of interleukin-6 is associated with disease progression of chronic HBV infection in a Chinese Han population.

Authors:  Shengli Tang; Zhisu Liu; Yongxi Zhang; Yueming He; Dingyu Pan; Yuanyuan Liu; Quanyan Liu; Zhonglin Zhang; Yufeng Yuan
Journal:  Dis Markers       Date:  2013-11-25       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.